IONIS PHARMACEUTICALS INC (IONS) Insider Trading -- Recent Executive & Director Transactions

21 insiders reported 371 Form 4 transactions for IONIS PHARMACEUTICALS INC (IONS) over the past 18 months (most recent 2026-07-31). Recent activity: Hayden Michael R (Director) Buy 5,000 shares, Hayden Michael R (Director) Buy 15,000 shares, BERTHELSEN SPENCER R (Director) Buy 5,220 shares, HERMAN JOAN E (Director) Buy 5,220 shares, BENNETT C FRANK (EVP, Chief Scientific Officer) Sell 5,536 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-07-31Hayden Michael RDirectorBuy5,000$258,000
2026-07-31Hayden Michael RDirectorBuy15,000$800,700
2026-07-17BERTHELSEN SPENCER RDirectorBuy5,220$0
2026-07-17HERMAN JOAN EDirectorBuy5,220$0
2026-07-09BENNETT C FRANKEVP, Chief Scientific OfficerSell5,536$462,693
2026-07-09Diaz Allene M.DirectorBuy10,111$476,329
2026-07-09Kordasiewicz Holly B.EVP, Chief Development OfficerSell362$30,517
2026-07-09BENNETT C FRANKEVP, Chief Scientific OfficerBuy15,000$0
2026-07-09Diaz Allene M.DirectorSell10,111$863,637
2026-07-09BENNETT C FRANKEVP, Chief Scientific OfficerSell15,000$1.3M
2026-07-06KLEIN JOSEPH IIIDirectorSell11,419$902,551
2026-07-06KLEIN JOSEPH IIIDirectorSell99$7,866
2026-07-06KLEIN JOSEPH IIIDirectorBuy11,518$460,029
2026-06-30O'NEIL PATRICK R.EVP CLO & General CounselSell3,069$245,520
2026-06-30Schneider EugeneEVP, Chf Clinical Develop OfcrBuy26,000$1.6M
2026-06-30Baroldi JosephEVP, Chief Business OfficerBuy1,769$57,669
2026-06-30Schneider EugeneEVP, Chf Clinical Develop OfcrSell26,000$2.1M
2026-06-30Baroldi JosephEVP, Chief Business OfficerSell5,635$451,699
2026-06-30Baroldi JosephEVP, Chief Business OfficerBuy3,866$219,511
2026-06-26Monia Brett PChief Executive OfficerBuy50,000$2.8M
2026-06-26Monia Brett PChief Executive OfficerBuy14,565$474,819
2026-06-26Swayze EricEVP ResearchSell10,602$839,492
2026-06-26Monia Brett PChief Executive OfficerSell14,565$1.1M
2026-06-26Monia Brett PChief Executive OfficerBuy21,072$686,947
2026-06-26Monia Brett PChief Executive OfficerSell21,072$1.7M

Source: SEC Form 4 filings · as of 2026-07-31